Log in to your Inderes Free account to see all free content on this page.
Cantargia
4.02 SEK
+0.25 %
1,287 following
CANTA
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Cantargia
P/E
Median 2019-2025
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 16.77 | 53.26 | 15.36 | 3.08 | 3.74 | 1.69 | 4.19 |
| Shares | 87.5 | 120.4 | 120.4 | 167.0 | 183.7 | 183.7 | 248.6 |
| Market cap | 1,467.0 | 6,412.3 | 1,849.6 | 514.3 | 686.6 | 310.4 | 1,040.4 |
| Enterprise value | 1,317.1 | 5,508.9 | 1,290.2 | 87.7 | 491.9 | 277.4 | - |
| EV/S | - | - | - | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | 7.1 |
| P/B | 10.31 | 7.19 | 3.47 | 1.32 | 4.07 | 2.67 | 3.91 |
| P/S | - | - | - | - | - | - | 3.3 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 85.7 % | 96.4 % | 88.8 % | 82.1 % | 75.4 % | 68.2 % | 89.6 % |
| Gearing ratio | - | - | - | - | - | - | - |
Login required
This content is only available for logged in users